Hemolysis

Hemolysis is a pathological process in which red blood cells (erythrocytes) are destroyed, releasing hemoglobin into the blood. Hemolysis can be either acquired or inherited, and it results in various clinical manifestations, such as anemia, jaundice, and increased strain on the filtration organs, particularly the liver and kidneys. There are two main types of hemolysis: intravascular, occurring within the vascular bed, and extravascular, occurring mainly in the spleen and liver. Hemolysis can be caused by infectious agents, immunological reactions, and mechanical cell damage, which is often seen with trauma or exposure to toxins.

History of the disease and interesting historical facts

Hemolysis was known in ancient times, but its mechanisms remained poorly understood until the 19th century. One of the first mentions of hemolysis in literature can be considered the works of Hippocrates, who described jaundice in his patients. Key figures in the study of hemolysis were scientists such as Emil von Berwi and Benjamin Rusch. In 1900, Carl Lenneck, observing hemolytic anemia, established a link between the destruction of red blood cells and the effects of infectious agents. The establishment of blood donation in the early 20th century was an important milestone in the treatment of hemolytic conditions, which made it possible to significantly reduce mortality associated with anemia caused by hemolysis.

Epidemiology

The epidemiology of hemolysis varies depending on its causes. According to the World Health Organization, hemolysis associated with hereditary diseases occurs with a frequency of 1 in 5,000 people. However, acquired hemolysis is most often observed in countries with highly developed medical systems, in particular as a result of autoimmune diseases or exposure to toxins. According to statistics, the frequency of hemolytic anemia in adults is approximately 3%, while in children it is about 1%. Current research shows that previous infections such as malaria can also lead to ineffective hemolysis, which further complicates the statistics.

Genetic predisposition to this disease

Genetic susceptibility to hemolysis is most often associated with inherited anemias such as thalassemia or sickle cell anemia. The main genes involved include HBB, which codes for the β-chain of hemoglobin. Mutations in this gene can cause ineffective red blood cell production. In addition, mutations in genes responsible for the synthesis of enzymes such as G6PD (glucose-6-phosphate dehydrogenase) can also lead to hemolysis. There is evidence that certain genetic variations may protect against hemolysis, especially in malaria-prone areas, creating the phenomenon of “potential resistance.”

Risk factors for the development of this disease

Risk factors that contribute to hemolysis can be both physical and chemical. The main ones include:

• Hereditary diseases such as sickle cell anemia and thalassemia.
• Infectious diseases (eg, malaria and viral hepatitis) leading to hemolysis.
• Exposure to toxins (eg, some drugs, pesticides) and chemicals.
• Mechanical damage such as trauma or cell aggregation.
• Immune disorders, including autoimmune diseases, that result in the formation of antibodies against one's own red blood cells.

Diagnosis of this disease

Diagnosis of hemolysis is based on identifying characteristic symptoms and confirming them with laboratory tests. The main symptoms may include:

• Jaundice.
• Fatigue and weakness.
• Enlarged spleen (splenomegaly).
• Increased heart rate.

Laboratory tests help establish a diagnosis and include:

• Complete blood count to detect anemia.
• Biochemical parameters such as bilirubin levels.
• Test for the presence of free hemoglobin in serum.
• Specialized tests for the presence of antibodies.

Radiological examinations may also be used to evaluate the organ, especially the spleen and liver. It is important to differentiate from other conditions such as iron deficiency anemia or aplastic anemia.

Treatment

Treatment of hemolysis requires an individual approach depending on its causes. General treatment may include supportive care such as blood transfusions. Pharmacological treatment often includes corticosteroids to reduce inflammation and immune response. In cases of autoimmune hemolysis, immunosuppressive drugs are used. Surgical treatment may be indicated if the spleen is significantly enlarged. Other treatments may include plasmapheresis and the use of specific monoclonal antibodies.

List of medications used to treat this disease

The main drugs used in the treatment of hemolysis include:

• Prednisolone.
• Dexamethasone.
• Cyclophosphamide.
• Rituximab.
• Hydroxyurethane.

Disease monitoring

Monitoring of hemolysis includes regular control blood tests, assessment of liver and kidney function, and dynamic observation of clinical symptoms. The prognosis depends on the nature of hemolysis, its cause, and the timeliness of treatment. Complications may include the development of chronic anemia and infections, including sepsis.

Age-related features of the disease

Hemolysis has different clinical manifestations depending on the age group. In newborns, hemolysis can be caused by Rh-conflict or blood group incompatibility, which often leads to jaundice. In children, hemolysis can occur as a result of infections, and in adults, there are usually specialized causes, such as autoimmune disorders or taking specific medications.

Questions and Answers

• What is hemolysis? Hemolysis is the process of destruction of red blood cells, resulting in the release of hemoglobin into the blood, which can lead to various clinical manifestations, including anemia.
• What are the main causative factors of hemolysis? The main factors include infectious agents, hereditary diseases, exposure to toxins and mechanical damage.
• How is hemolysis diagnosed? Diagnosis includes a complete blood count, biochemical tests, and additional tests such as an antibody test.
• What is the treatment for hemolysis? Treatment may include drug therapy, supportive care, blood transfusions, and, in some cases, surgery.
• What is the prognosis for hemolysis? The prognosis depends on its causes and the timeliness of treatment; severe forms of hemolysis may have a risk of developing chronic complications.

Advice from Dr. Oleg Korzhikov

In hemolysis, it is important to understand that successful treatment largely depends on early and accurate diagnosis. I recommend using the following tips:

• Get regular medical checkups, especially if you have risk factors.
• Watch for any unusual symptoms, such as fatigue and jaundice, and seek medical attention immediately.
• Follow your doctor's instructions regarding medications and monitor the dynamics of your condition.

Remember that a healthy lifestyle and prevention of infectious diseases can significantly reduce the risk of developing hemolytic conditions.